CINN logo
Make an AppointmentRefer a PatientContact Us Site Map
CINN Medical Services > Treatments & Technology > Vertebroplasty

Vertebroplasty: A Minimally Invasive Option for Older Osteoporotic Patients

Patients at Risk for Vertebral Compression Fracture
Postmenopausal women
Individuals on chronic steroid therapy
Individuals with renal failure
Individuals subjected to lengthy immobilization

Osteoporosis is the most common metabolic bone disorder and the leading cause of vertebral compression fracture (VCF). Up to 700,000 VCFs occur each year in the United States. Vertebroplasty is a relatively new, minimally invasive technique that offers effective treatment for VCF by utilizing bone cement to stabilize the fractures. The procedure, which involves the minimally invasive delivery of Polymethyl Methacrylate (PMMA), offers early relief to older patients suffering osteoporotic compression fractures and refractory pain, with studies reporting over 80 percent success.(1)

Vertebroplasty is also used to treat steroid-induced osteoporotic compression fractures, vertebral body hemangiomas and metastatic disease of the spine.(2) “Vertebroplasty is an interventional option for a patient population that previously had no such option,” says Kenneth S. Heiferman, M.D., associate director of the Institute for Spine Care at Elmhurst Memorial Hospital. “The benefit of vertebroplasty is that it is relatively easy on the patient,” Heiferman explains. “It requires minimal sedation, which is good for older patients. And it offers rapid relief of pain. The patient can return to normal function much quicker,” says Heiferman.

“Traumatic or spontaneous compression fractures can change a patient’s entire life,” says Marc A. Levin, M.D., medical director of CINN at Community Hospital in Munster, Indiana. “If left untreated, VCFs will continue to cause pain. Posterior displacement of the vertebral body can occur, which can cause pressure on nerves of the spinal cord and can lead to neurological deficit,” Levin explains. “Vertebroplasty stabilizes or hardens the fracture, thus reducing the pain.”

Traditional treatments for VCF, such as bed rest, bracing, narcotics and injections, are largely ineffective, as they often do not provide significant pain relief and, most importantly, do not address the underlying fracture or prevent further collapse of the vertebral body. Vertebral fractures can cause incapacitating pain lasting for months with associated disability and potential morbidity.(3)

Considerations

In most cases, vertebroplasty should be considered after 4-6 weeks of conservative therapy. However, some experts advocate vertebroplasty in the acute setting to relieve pain in elderly patients, since vertebroplasty may pose less risk and discomfort than the potential complications of immobility. Patients selected for vertebroplasty often have multiple medical conditions. Some patients with extensive pulmonary disease may not be candidates for the procedure. Others may not tolerate lying prone, which is necessary for the duration of the procedure. An office trial, in which a patient is placed in a prone position, can help identify those who may not tolerate the procedure. Vertebroplasty should never be used as the sole therapy in cases of spinal instability. Patients with spinal instability, spinal cord compression or epidural extension of pathology are candidates for surgery. In cases of severe osteoporosis requiring spinal stabilization, percutaneous Polymethyl Methacrylate (PMMA) injection may augment pedicle screw fixation. Vertebroplasty is not appropriate for patients with leg problems.(4)

Contraindications

Contraindications for the procedure include: severe wedge deformity in which the vertebral body is less than 10 percent the normal height; comminuted burst fragment; severe pulmonary edema or chronic obstructive pulmonary disease; coagulopathy; uncertain cause of pain. Leg pain, tingling, numbness or weakness in the legs implies nerve compression; vertebroplasty is not an effective treatment for nerve compression.

Procedure Overview

Injection of PMMA under constant fluoroscopic guidance.

Vertebroplasty is generally performed under local anesthesia. The patient is placed in a prone position with padding under the torso and the hips in slight flexion. The arms are positioned above the shoulder, pressure points are padded, and joints are gently flexed. A needle is placed in the vertebral body under direct visualization using fluoroscopy. Polymethyl Methacrylate (PMMA) is injected under high pressure and constant fluoroscopic guidance. At the completion of the procedure the needle is removed and a single subcuticular stitch or a Steri-Strip is placed.(5, 6)

Postoperative Care

The patient is maintained in a recumbent position for two hours following the procedure and then allowed to sit and to ambulate with assistance. Pain relief is significant and if percutaneous passage of the needle was not accompanied by numerous redirections, paraspinal muscle spasm may be minimal following the procedure. Patients are discharged home with muscle relaxants and nonsteroidal anti-inflammatory medications. If the procedure is performed in the morning, the patient may be discharged the same day and is encouraged to remain active by ambulating and performing activities of daily living.(7)

Complications

Complications of vertebroplasty are relatively rare in the treatment of osteoporotic compression fractures (approximately 1.3 percent). The most common complications following vertebroplasty are rib fracture and radiculopathy.(8)

1 Vertebroplasty-Kyphoplasty: Potentially the Biggest Near-Term Orthopaedic Opportunity, Orthopaedic Convention Preview—U.S. Bancorp Piper Jaffray Equity Research, March 2000, 20-21, 41.

2 Mick J. Perez-Cruet and Richard G. Fessler, eds.: Outpatient Spinal Surgery (St. Louis: Quality Medical Publishing, Inc., 2002), 231-241.

3 Vertebroplasty-Kyphoplasty: Potentially the Biggest Near-Term Orthopaedic Opportunity, Orthopaedic Convention Preview—U.S. Bancorp Piper Jaffray Equity Research, March 2000, 20-21, 41.

4 Mick J. Perez-Cruet and Richard G. Fessler, eds: Outpatient Spinal Surgery (St. Louis: Quality Medical Publishing, Inc., 2002), 231-241.

5 Vertebroplasty-Kyphoplasty: Potentially the Biggest Near-Term Orthopaedic Opportunity, Orthopaedic Convention Preview—U.S. Bancorp Piper Jaffray Equity Research, March 2000, 20-21, 41.

6 Mick J. Perez-Cruet and Richard G. Fessler, eds: Outpatient Spinal Surgery (St. Louis: Quality Medical Publishing, Inc., 2002), 231-241.

7 Ibid.

8 Ibid.

ABOUT CINN: PHYSICIANS | LOCATIONS | NEWS & EVENTS | OUR QUALIFICATIONS
AREAS OF EXPERTISE: PAIN | SPINE | BRAIN TUMOR | VASCULAR | NEUROLOGIC CONDITIONS | OTHER CRANIAL DISORDERS
MEDICAL SERVICES: DIAGNOSTIC TESTS | TREATMENTS & TECHNOLOGY | WORK INJURY CARE | CLINICAL TRIALS
APPOINTMENTS | REFER A PATIENT | CONTACT US | HOME
Copyright 2007, Chicago Institute of Neurosurgery and Neuroresearch, 4501 N Winchester Ave, Chicago, IL 60640 1-800-411-(CINN) 2466